Clinical Trials Directory

Trials / Completed

CompletedNCT01086241

Tomosynthesis in Screening Mammography

A Study to Determine Patient Benefit of Tomosynthesis in Screening Mammography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
500 (actual)
Sponsor
AHS Cancer Control Alberta · Academic / Other
Sex
Female
Age
40 Years – 69 Years
Healthy volunteers
Not accepted

Summary

Tomosynthesis is a new digital mammographic tool which can be performed at the same time as routine screening mammography. It creates CT-like slices through the breast, minimizing the tissue overlap. Tomosynthesis has the potential to improve screening mammography outcomes by increasing cancer detection rates, decreasing false negative rates and false positive rates. This trial will help determine if tomosynthesis is useful in a screening setting.

Detailed description

We will evaluate the effect of tomosynthesis mammography outcomes in a screening setting. We will collect data on interpretation time, recall rates, cancer detection rates, and interval cancer rates in dense breasts(≥ 50% glandular density). If the interpretation time is less than 4X a routine read, and the recall rates have dropped \< 30% of initial values, we will then conduct a study with larger numbers to better evaluate cancer detection rates and interval cancer rates.

Conditions

Interventions

TypeNameDescription
PROCEDURE2D MammogramThose patients randomized to the mammogram arm will receive a regular 2D mammogram. Compression lasts several seconds in order to obtain 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.
PROCEDURETomosynthesisThose patients randomized to the tomosynthesis arm will receive a combination of 3D and 2D screening mammogram. The additional tomosynthesis data is obtained immediately after acquisition of the 2D study, with the patient and breast remaining in the same position and compression. Compression lasts about 7 seconds longer for each of the 4 views. The x-ray tube is programmed to obtain an arc of low dose projection images through the breast.

Timeline

Start date
2010-05-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2010-03-15
Last updated
2025-06-29

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01086241. Inclusion in this directory is not an endorsement.